PortfoliosLab logo
DGX vs. ^SP500TR
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between DGX and ^SP500TR is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

DGX vs. ^SP500TR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quest Diagnostics Incorporated (DGX) and S&P 500 Total Return (^SP500TR). The values are adjusted to include any dividend payments, if applicable.

1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%6,000.00%7,000.00%NovemberDecember2025FebruaryMarchApril
6,813.07%
1,176.73%
DGX
^SP500TR

Key characteristics

Sharpe Ratio

DGX:

1.33

^SP500TR:

0.54

Sortino Ratio

DGX:

2.15

^SP500TR:

0.88

Omega Ratio

DGX:

1.26

^SP500TR:

1.13

Calmar Ratio

DGX:

1.65

^SP500TR:

0.56

Martin Ratio

DGX:

8.08

^SP500TR:

2.30

Ulcer Index

DGX:

3.67%

^SP500TR:

4.55%

Daily Std Dev

DGX:

22.34%

^SP500TR:

19.44%

Max Drawdown

DGX:

-49.46%

^SP500TR:

-55.25%

Current Drawdown

DGX:

-1.32%

^SP500TR:

-9.86%

Returns By Period

In the year-to-date period, DGX achieves a 16.31% return, which is significantly higher than ^SP500TR's -5.68% return. Over the past 10 years, DGX has underperformed ^SP500TR with an annualized return of 11.64%, while ^SP500TR has yielded a comparatively higher 12.27% annualized return.


DGX

YTD

16.31%

1M

4.35%

6M

13.17%

1Y

32.04%

5Y*

11.53%

10Y*

11.64%

^SP500TR

YTD

-5.68%

1M

-0.91%

6M

-4.24%

1Y

9.81%

5Y*

15.89%

10Y*

12.27%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DGX vs. ^SP500TR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DGX
The Risk-Adjusted Performance Rank of DGX is 8989
Overall Rank
The Sharpe Ratio Rank of DGX is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of DGX is 8888
Sortino Ratio Rank
The Omega Ratio Rank of DGX is 8484
Omega Ratio Rank
The Calmar Ratio Rank of DGX is 9191
Calmar Ratio Rank
The Martin Ratio Rank of DGX is 9393
Martin Ratio Rank

^SP500TR
The Risk-Adjusted Performance Rank of ^SP500TR is 7777
Overall Rank
The Sharpe Ratio Rank of ^SP500TR is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of ^SP500TR is 7373
Sortino Ratio Rank
The Omega Ratio Rank of ^SP500TR is 7676
Omega Ratio Rank
The Calmar Ratio Rank of ^SP500TR is 8080
Calmar Ratio Rank
The Martin Ratio Rank of ^SP500TR is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DGX vs. ^SP500TR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and S&P 500 Total Return (^SP500TR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for DGX, currently valued at 1.33, compared to the broader market-2.00-1.000.001.002.003.00
DGX: 1.33
^SP500TR: 0.54
The chart of Sortino ratio for DGX, currently valued at 2.15, compared to the broader market-6.00-4.00-2.000.002.004.00
DGX: 2.15
^SP500TR: 0.88
The chart of Omega ratio for DGX, currently valued at 1.26, compared to the broader market0.501.001.502.00
DGX: 1.26
^SP500TR: 1.13
The chart of Calmar ratio for DGX, currently valued at 1.65, compared to the broader market0.001.002.003.004.005.00
DGX: 1.65
^SP500TR: 0.56
The chart of Martin ratio for DGX, currently valued at 8.08, compared to the broader market-5.000.005.0010.0015.0020.00
DGX: 8.08
^SP500TR: 2.30

The current DGX Sharpe Ratio is 1.33, which is higher than the ^SP500TR Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of DGX and ^SP500TR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00NovemberDecember2025FebruaryMarchApril
1.33
0.54
DGX
^SP500TR

Drawdowns

DGX vs. ^SP500TR - Drawdown Comparison

The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum ^SP500TR drawdown of -55.25%. Use the drawdown chart below to compare losses from any high point for DGX and ^SP500TR. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-1.32%
-9.86%
DGX
^SP500TR

Volatility

DGX vs. ^SP500TR - Volatility Comparison

The current volatility for Quest Diagnostics Incorporated (DGX) is 9.76%, while S&P 500 Total Return (^SP500TR) has a volatility of 14.21%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than ^SP500TR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
9.76%
14.21%
DGX
^SP500TR